NO932236D0 - Farmasoeytisk preparat inneholdende probukol med forhoeyet biotilgjengelighet - Google Patents

Farmasoeytisk preparat inneholdende probukol med forhoeyet biotilgjengelighet

Info

Publication number
NO932236D0
NO932236D0 NO1993932236A NO932236A NO932236D0 NO 932236 D0 NO932236 D0 NO 932236D0 NO 1993932236 A NO1993932236 A NO 1993932236A NO 932236 A NO932236 A NO 932236A NO 932236 D0 NO932236 D0 NO 932236D0
Authority
NO
Norway
Prior art keywords
probukol
pharmaceutical preparation
preparation containing
fatty acids
bio availability
Prior art date
Application number
NO1993932236A
Other languages
English (en)
Other versions
NO932236L (no
NO303526B1 (no
Inventor
Kenneth G Bassler
Deepak S Phadke
Melissa P Neddermeyer
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of NO932236L publication Critical patent/NO932236L/no
Publication of NO932236D0 publication Critical patent/NO932236D0/no
Publication of NO303526B1 publication Critical patent/NO303526B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/10—Sulfides; Sulfoxides; Sulfones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Hematology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO932236A 1990-12-18 1993-06-17 FremgangsmÕte for fremstilling av et farmas°ytisk preparat inneholdende probukol med forh°yet biotilgjengelighet NO303526B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US62954090A 1990-12-18 1990-12-18
PCT/US1991/008565 WO1992010996A1 (en) 1990-12-18 1991-11-15 Enhanced bioavailability pharmaceutical composition containing probucol

Publications (3)

Publication Number Publication Date
NO932236L NO932236L (no) 1993-06-17
NO932236D0 true NO932236D0 (no) 1993-06-17
NO303526B1 NO303526B1 (no) 1998-07-27

Family

ID=24523438

Family Applications (1)

Application Number Title Priority Date Filing Date
NO932236A NO303526B1 (no) 1990-12-18 1993-06-17 FremgangsmÕte for fremstilling av et farmas°ytisk preparat inneholdende probukol med forh°yet biotilgjengelighet

Country Status (17)

Country Link
EP (1) EP0563112B1 (no)
JP (1) JP3127998B2 (no)
KR (1) KR0177845B1 (no)
AT (1) ATE117200T1 (no)
AU (1) AU647563B2 (no)
CA (1) CA2097827C (no)
DE (1) DE69106892T2 (no)
DK (1) DK0563112T3 (no)
ES (1) ES2069987T3 (no)
FI (1) FI102457B1 (no)
GR (1) GR3015837T3 (no)
HU (1) HU210565B (no)
IE (1) IE65578B1 (no)
IL (1) IL100390A (no)
NO (1) NO303526B1 (no)
NZ (1) NZ240961A (no)
WO (1) WO1992010996A1 (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2517095A (en) * 1994-05-19 1995-12-18 R.P. Scherer International Corporation Solutions of aryl or heteroaryl substituted alkanoic acids in lipophilic solvents and soft gelatin capsules containing such solutions
US5858401A (en) 1996-01-22 1999-01-12 Sidmak Laboratories, Inc. Pharmaceutical composition for cyclosporines
US6838091B2 (en) 1998-12-18 2005-01-04 Abbott Laboratories Formulations comprising lipid-regulating agents
US7014864B1 (en) 1998-12-18 2006-03-21 Abbott Laboratories Formulations comprising lipid-regulating agents
US6814977B1 (en) 1998-12-18 2004-11-09 Abbott Laboratories Formulations comprising lipid-regulating agents
CA2355820A1 (en) * 1998-12-18 2000-06-29 Abbott Laboratories Novel formulations comprising lipid-regulating agents
AU2571400A (en) * 1999-02-23 2000-09-14 Chugai Seiyaku Kabushiki Kaisha Seam soft capsule preparations containing dihydrobenzofuran derivative
US6719999B2 (en) 1999-03-31 2004-04-13 Abbott Laboratories Formulations comprising lipid-regulating agents
US6372251B2 (en) 1999-06-11 2002-04-16 Abbott Laboratories Formulations comprising lipid-regulating agents
WO2005037251A1 (en) * 2003-10-17 2005-04-28 Amylin Pharmaceuticals, Inc. Self-emulsifying drug delivery systems for hydrophobic therapeutic compounds
EP4397369A3 (en) 2018-06-26 2024-09-25 Ribonova Inc. Methods of treating mitochondrial dysfunction
WO2024006748A1 (en) * 2022-07-01 2024-01-04 Acrotech Biopharma Inc. Pharmaceutical compositions comprising isotretinoin and processes for preparation and uses thereof
CN116617179B (zh) * 2023-05-19 2024-03-29 齐鲁制药有限公司 一种普罗布考软胶囊及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3862332A (en) * 1967-05-11 1975-01-21 Dow Chemical Co Method of lowering serum cholesterol
US4902513A (en) * 1987-07-31 1990-02-20 Jean Carvais Oral sustained release medicament

Also Published As

Publication number Publication date
JPH06503340A (ja) 1994-04-14
FI102457B (fi) 1998-12-15
AU647563B2 (en) 1994-03-24
NO932236L (no) 1993-06-17
HUT64218A (en) 1993-12-28
CA2097827A1 (en) 1992-06-19
DE69106892T2 (de) 1995-05-18
HU210565B (en) 1995-05-29
GR3015837T3 (en) 1995-07-31
FI932769A (fi) 1993-06-16
NZ240961A (en) 1994-03-25
EP0563112A1 (en) 1993-10-06
EP0563112B1 (en) 1995-01-18
IE914401A1 (en) 1992-07-01
WO1992010996A1 (en) 1992-07-09
IL100390A (en) 1996-12-05
KR0177845B1 (ko) 1999-03-20
IL100390A0 (en) 1992-09-06
KR930702965A (ko) 1993-11-29
JP3127998B2 (ja) 2001-01-29
IE65578B1 (en) 1995-11-01
NO303526B1 (no) 1998-07-27
FI932769A0 (fi) 1993-06-16
HU9301769D0 (en) 1993-09-28
CA2097827C (en) 2002-07-23
FI102457B1 (fi) 1998-12-15
DE69106892D1 (de) 1995-03-02
ES2069987T3 (es) 1995-05-16
AU9067891A (en) 1992-07-22
ATE117200T1 (de) 1995-02-15
DK0563112T3 (da) 1995-04-10

Similar Documents

Publication Publication Date Title
ATE153854T1 (de) Stabile pharmazeutische zubereitung mit fumagillolderivaten
IT8721453A0 (it) Acidi poliinsaturi ad azione vasocinetica e relative formulazioni farmaceutiche e cosmetiche.
NO932236D0 (no) Farmasoeytisk preparat inneholdende probukol med forhoeyet biotilgjengelighet
ATE76747T1 (de) Levodopa-methyl-ester enthaltende pharmazeutische zusammensetzungen, ihre herstellung und therapeutische verwendungen.
DE3868037D1 (de) Pharmazeutische zusammensetzung mit verzoegerter wirkstoffabgabe.
IT1246188B (it) Procedimento per la preparazione di composizioni farmaceutiche aventi aumentata velocita' di dissoluzione della sostanza attiva e composizioni ottenute.
NO176082C (no) Fremgangsmåte for fremstilling av et farmasöytisk preparat inneholdende bunazosin, for perkutan tilförsel
DK585889A (da) Farmaceutisk praeparat
MX9101035A (es) Quinazolinonas biologicamente activas y composicion farmaceutica que las contiene
BE1002024A6 (fr) Preparation medicamenteuse a base de derives d'esters d'hecogenine et leur utilisation pour le traitement de l'hyperplasie prostatique benigne.
IT1204571B (it) Esteri di 1,4:3,6-dianidrosorbitolo-2-mononitrato e 5-mononitrato,loro procedimento di preparazione e loro composizioni farmaceutiche
NO307126B1 (no) Anvendelse av biologisk aktive ureidoderivater for fremstilling av et medikament for bruk i behandlingen av lentivirusindusert sykdom
SE8104657L (sv) Injicerbara farmaceutiska kompositioner
IT8619288A0 (it) Formulazioni farmaceutiche iniettabili di principi attivi adattivita' anestetica generale.
ES2051864T3 (es) Un procedimiento para preparar una composicion farmaceutica con actividad anti-cancer.
IT8821369A0 (it) Composizione farmaceutica utile per il trattamento di malattie cardiovascolari.
NO171295C (no) Fremgangsmaate for fremstilling av et farmasoeytisk preparat i form av et biologisk aktivt konjugert protein
ITMI911206A0 (it) Formulazioni farmaceutiche per il trattamento di malattie periferiche vascolari
IT8620737A1 (it) Composizioni farmaceutiche contenenti levodopa metil estere, loro procedimento di preparazione e relative applicazioni terapeutiche
IT8719888A0 (it) Formulazioni farmaceutiche iniettabili di principi attivi adattivita' anestetica generale.
SE9002067D0 (sv) The pharmacological use of certain cystine derivatives
CS9001479A2 (en) Injection drug form on base of luteolytically active analogue of prostaglandin
DZ1600A1 (fr) Compositions pharmaceutiques anti-glaucomateurses et leur procédé d'obtention.
NO943458L (no) Fremgangsmåte for fremstilling av terapeutisk aktivt amphiregulin
ITMI921749A0 (it) Composizione farmaceuticaidrofila ad attivita' antiinfiammatoria

Legal Events

Date Code Title Description
MK1K Patent expired